Drug Database
Back to search

Netherlands· NL-cf4ee1032310

Kapruvia 50 microgram/ml oplossing voor injectie

A difelikefalin product containing difelikefalineacetaat, registered in Netherlands by Vifor Fresenius Medical Care Renal Pharma France. The same ATC class is registered in 14 of our 19 countries.

ATC V03AX04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedKapruvia 50 microgram/ml oplossing vo…ATCV03AX04REGISTER NO.NL-cf4ee1032310PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about difelikefalineacetaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Difelikefalin is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AX04 (difelikefalin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search difelikefalin products by name

Difelikefalin · ATC V03AX04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIFELIKEFALINEACETAAT
Manufacturer
Vifor Fresenius Medical Care Renal Pharma France
Country
Netherlands (NL)
ATC code
V03AX04
ATC class
Difelikefalin
Defined daily dose
15 mcg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/22/1643

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Difelikefalin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All difelikefalin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kapruvia
  • Liechtenstein · Kapruvia
  • Norway · Kapruvia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d57aec30-864e-4d5c-a0cf-fca4e18dc035
GET /v1/drugs/d57aec30-864e-4d5c-a0cf-fca4e18dc035?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Hemodialyse",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kapruvia-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Difelikefalin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128106",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DIFELIKEFALINEACETAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/04/25",
  "procedure_number": "EMEA/H/C/005612",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1643",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about difelikefalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console